Yüklüyor......
New developments in the anti-neoplastic drug management of ovarian cancer
Over the past several years, there have been a number of relevant evidence-based randomized trials that have the potential to change the standard management paradigm in the malignancy of ovarian cancer and (most importantly) enhance clinically relevant outcomes. This commentary will briefly review t...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Faculty of 1000 Ltd
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3816763/ https://ncbi.nlm.nih.gov/pubmed/24273649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/P5-48 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|